OSA - Obstructive Sleep Apnea
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Sciwind BiosciencesChina - Hangzhou
2 programs2
XW003 injectionPhase 31 trial
XW003 injectionPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
Sciwind BiosciencesXW003 injection
Sciwind BiosciencesXW003 injection
ApnimedAD109
Clinical Trials (3)
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Start: Mar 2026Est. completion: Jun 2028
Phase 3Not Yet Recruiting
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Start: Mar 2026Est. completion: Dec 2027
Phase 3Not Yet Recruiting
Parallel Arm Trial of AD109 and AD504 In Patients With OSA
Start: Nov 2021Est. completion: Aug 2022
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space